DCR-PHXC-101

· Dicerna Pharmaceuticals, a Novo Nordisk company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCR-PHXC-101, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria [Phase 1]